BRUSHIELD Trademark

Trademark Overview

On Wednesday, July 14, 2021, a trademark application was filed for BRUSHIELD with the United States Patent and Trademark Office. The USPTO has given the BRUSHIELD trademark a serial number of 90827142. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by pacDNA LLC. The BRUSHIELD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
brushield

General Information

Serial Number90827142
Word MarkBRUSHIELD
Filing DateWednesday, July 14, 2021
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7262782
Registration DateTuesday, January 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements

Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 17, 2021
Primary Code042
First Use Anywhere DateThursday, January 6, 2022
First Use In Commerce DateMonday, September 12, 2022

Trademark Owner History

Party NamepacDNA LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNatick, MA 01760
Party NamepacDNA LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNatick, MA 01760
Party NamepacDNA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNatick, MA 01760

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, November 30, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 29, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 28, 2023ASSIGNED TO LIE
Friday, June 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 10, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 10, 2023SU - NON-FINAL ACTION - WRITTEN
Friday, March 24, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 16, 2022USE AMENDMENT FILED
Monday, December 5, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 16, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, July 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 4, 2022ASSIGNED TO EXAMINER
Friday, September 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 17, 2021NEW APPLICATION ENTERED

Related Keywords

brushield development research pharmaceutical